Cite

HARVARD Citation

    Fumery, M. et al. (n.d.). OP24 Effectiveness and safety of ustekinumab 90 mg every 4 weeks in Crohn's disease. Journal of Crohn's and colitis. p. S016. [Online]. 
  
Back to record